Merck & Co., Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Merck & Co., Inc.
CIK #0000310158
Sector Form 13F Holdings Value ($M)
Personalis Inc 92.1
Moderna Inc 63.7
Kymera Therapeutics Inc 33.7
Alector Inc 5.0
Evaxion Biotech A/S 3.0
Sutro Biopharma Inc 1.9
LAVA Therapeutics NV 1.5
Signal Genetics Inc 1.3
Xilio Therapeutics Inc 1.0
Eleven Biotherapeutics Inc 0.6
View All
Holdings by Sector ($M)
2502001501005002024202420252026
EDGAR Form CIK 2011 - 2025
10-K [0000310158]
10-Q [0000310158]
13F-HR [0000310158]
3 [0000310158]
4 [0000310158]
5 [0000310158]
8-K [0000310158]
SC 13D [0000310158]
SC 13G [0000310158]
Form 13D/13G Filer Form 13D/13G Subject Filed
Merck & Co Inc Personalis Inc [2024-12-23]
Merck & Co Inc Evaxion Biotech A/S [2024-01-23]
Merck & Co Inc 4D Pharma PLC [2022-02-02]
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04]
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04]
Merck & Co Inc Arqule Inc [2019-12-16]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Merck & Co Inc Alector Inc [2019-02-14]
Merck & Co Inc Sutro Biopharma Inc [2018-10-04]
Merck & Co Inc Menlo Therapeutics Inc [2018-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Merck & Co., Inc.
Guindo Chirfi
Williams David Michael
Coe Mary Ellen
Glocer Thomas H
Seidman Christine E
Craig Pamela J.
Lavizzo-Mourey RISA J
Karsanbhai Surendralal Lanca
Baker Douglas M Jr
View All
Terms | Privacy | Guide
tony@aum13f.com